Kathianne
11-25-2012, 08:34 PM
I.e., keep it in your pants:
http://www.bloomberg.com/news/2012-11-22/super-gonorrhea-bugs-spur-new-treatment-regimen-in-europe.html
Super Gonorrhea Bugs Spur New Treatment Regimen in Europe
<cite class="byline"> By Jason Gale - Nov 22, 2012 5:12 PM CT
...
</cite>The changes, outlined in a report (http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20323) yesterday in the European Centre for Disease Prevention and Control (http://www.ecdc.europa.eu/)’s weekly journal Eurosurveillance, are in response to sporadic cases in which ceftriaxone and a similar antibiotic, cefixime, failed to eliminate Neisseria gonorrhoeae, the microbial cause of gonorrhea.
N. gonorrhoeae has developed resistance to all antimicrobial drugs previously used as first-line treatment (http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20200). The once easily-treated infection is becoming a “major public health challenge,” the World Health Organization (http://topics.bloomberg.com/world-health-organization/) said in June. In 2008, the Geneva-based WHO estimated 106 million cases among adults worldwide, including 3.4 million in the agency’s European region.
“Gonorrhea now poses a potential public health disaster, with a very real threat that it may soon be untreatable in certain circumstances,” researchers in Sydney and Brisbane said in research published in the Journal of Antimicrobial Chemotherapy in May in which they recommended cases be treated with azithromycin plus ceftriaxone or a similar drug.
...
<cite class="byline">
</cite>
http://www.bloomberg.com/news/2012-11-22/super-gonorrhea-bugs-spur-new-treatment-regimen-in-europe.html
Super Gonorrhea Bugs Spur New Treatment Regimen in Europe
<cite class="byline"> By Jason Gale - Nov 22, 2012 5:12 PM CT
...
</cite>The changes, outlined in a report (http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20323) yesterday in the European Centre for Disease Prevention and Control (http://www.ecdc.europa.eu/)’s weekly journal Eurosurveillance, are in response to sporadic cases in which ceftriaxone and a similar antibiotic, cefixime, failed to eliminate Neisseria gonorrhoeae, the microbial cause of gonorrhea.
N. gonorrhoeae has developed resistance to all antimicrobial drugs previously used as first-line treatment (http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20200). The once easily-treated infection is becoming a “major public health challenge,” the World Health Organization (http://topics.bloomberg.com/world-health-organization/) said in June. In 2008, the Geneva-based WHO estimated 106 million cases among adults worldwide, including 3.4 million in the agency’s European region.
“Gonorrhea now poses a potential public health disaster, with a very real threat that it may soon be untreatable in certain circumstances,” researchers in Sydney and Brisbane said in research published in the Journal of Antimicrobial Chemotherapy in May in which they recommended cases be treated with azithromycin plus ceftriaxone or a similar drug.
...
<cite class="byline">
</cite>